Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 10.02% vs 16.66% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 24.02% vs 101.82% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 70.51% vs 46.50% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 150.00% vs 0.00% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

28.66

Other Operating Income

0.00

Total Operating income

28.66

Raw Material Cost

10.54

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.18

Employee Cost

1.35

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

10.52

0.00

10.52

Total Expenditure (Excl Depreciation)

22.59

Operating Profit (PBDIT) excl Other Income

6.07

0.00

6.07

Other Income

0.48

Operating Profit (PBDIT)

6.55

Interest

0.05

Exceptional Items

0.00

Gross Profit (PBDT)

6.50

Depreciation

0.94

Profit Before Tax

5.55

Tax

1.42

Provisions and contingencies

0.00

Profit After Tax

4.13

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.13

Equity Capital

12.30

Face Value

10.00

0.00

Reserves

94.13

Earnings per share (EPS)

3.36

Diluted Earnings per share

3.36

Operating Profit Margin (Excl OI)

21.18%

0.00

21.18%

Gross Profit Margin

22.68%

0.00

22.68%

PAT Margin

14.41%

0.00

14.41%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 28.66 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 10.02% vs 16.66% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -17.31% vs 33.87% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 4.13 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 24.02% vs 101.82% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -51.98% vs 75.87% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6.07 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 70.51% vs 46.50% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -46.80% vs 54.82% in Sep 2024

Quarterly - Interest

Interest 0.05 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 150.00% vs 0.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 66.67% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 21.18%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024